Literature DB >> 21425120

Behavior of aqueous nanocrystalline hydroxyapatite in oral bone regeneration.

Davide Zaffe1, Giorgio Traversa, Marco Mozzati, Fabrizio Morelli, Giovanni D'Angeli.   

Abstract

PURPOSE: A skeletal segment consisting exclusively of bone is the target outcome of bone regeneration. Granular hydroxyapatites form a hydroxyapatite-bone composite, unsuitable for effectively supporting implants, which may persist for many years. This work aimed to investigate the reasons for the bone replacement of Ostim®, a recently commercialized aqueous nanocrystalline hydroxyapatite.
METHODS: Histology, SEM and X-ray microanalysis were employed to analyze 6- to 9-month biopsies of post-extractive sites or sinus floor lifts of the maxilla in 15 subjects.
RESULTS: The results highlight a great bone formation, Ostim® resorption with time by osteoclasts but also interstitial fluid propagation of Ostim® masses by percolation. A possible osteocyte protoplasmic involvement was also at work in concert to reach the target.
CONCLUSIONS: The use of Ostim® as bone regenerating material leads to the formation of a highly suitable implant support consisting exclusively of bone in less than 12 months, i.e. in a remarkably short time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425120     DOI: 10.5301/JABB.2011.6450

Source DB:  PubMed          Journal:  J Appl Biomater Biomech        ISSN: 1722-6899


  2 in total

1.  Comparative Study on the Efficacy of Anorganic Bovine Bone (Bio-Oss) and Nanocrystalline Hydroxyapatite (Ostim) in Maxillary Sinus Floor Augmentation.

Authors:  Adileh Shirmohammadi; Leila Roshangar; Mohammad Taghi Chitsazi; Reza Pourabbas; Masoumeh Faramarzie; Nasrin Rahmanpour
Journal:  Int Sch Res Notices       Date:  2014-10-29

2.  Comparison of nanoparticular hydroxyapatite pastes of different particle content and size in a novel scapula defect model.

Authors:  Veronika Hruschka; Stefan Tangl; Yulia Ryabenkova; Patrick Heimel; Dirk Barnewitz; Günter Möbus; Claudia Keibl; James Ferguson; Paulo Quadros; Cheryl Miller; Rebecca Goodchild; Wayne Austin; Heinz Redl; Thomas Nau
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.